cholinergic receptor
7 drugs CNS
2
approved indications
7
Approved Drugs
6
Companies
2
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (6 companies)
✓ All 7 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (2 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
Fresenius Kabi 2 drugs
DOUGLAS PHARMS 1 drug
Teva 1 drug
By Therapeutic Area
Other 6 drugs
CNS 1 drugs
Drugs by Company PRO
Fresenius Kabi 2 drugs
DOUGLAS PHARMS 1 drug
Teva 1 drug
Hikma 1 drug
Dr. Reddy's 1 drug
Pfizer 1 drug
By Therapeutic Area
Other 6 drugs
ROCURONIUM BROMIDE, CLOZAPINE, CISATRACURIUM BESYLATE, CISATRACURIUM BESYLATE PRESERVATIVE FREE +2 more
CNS 1 drugs
VERSACLOZ
Indications Treated
SchizophreniaSchizoaffective Disorder
All Drugs Targeting cholinergic receptor
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| VERSACLOZ | DOUGLAS PHARMS | 2013 | 2 | CNS |
| ROCURONIUM BROMIDE | Fresenius Kabi | 2008 | - | |
| CLOZAPINE | Teva | 1996 | - | |
| CISATRACURIUM BESYLATE | Hikma | 2012 | - | |
| CISATRACURIUM BESYLATE PRESERVATIVE FREE | Fresenius Kabi | 2012 | - | |
| SUCCINYLCHOLINE CHLORIDE | Dr. Reddy's | 1972 | - | |
| QUELICIN | Pfizer | 1953 | - |